Company Filing History:
Years Active: 2024
Title: An Overview of Inventor Sebastian Zinn and His Contributions to Pain Management
Introduction
Sebastian Zinn is an innovative inventor based in Frankfurt-am-Main, Germany. With a profound understanding of the medical field, he has made significant contributions to the treatment of neuropathic pain through his groundbreaking patent.
Latest Patents
Sebastian Zinn holds one notable patent titled "CYP2J2 antagonists in the treatment of pain." This invention focuses on novel treatments for neuropathic pain, particularly chemotherapy-induced peripheral neuropathic pain (CIPNP). The patent provides insights into the use of antagonists targeting cytochrome P450 epoxygenases (CYP), specifically CYP2J2, which serve as therapeutics for alleviating neuropathic pain. The findings indicate that these antagonists can ease CIPNP in-vivo, enhancing the effectiveness of chemotherapeutics during cancer treatments by allowing for higher dosing. Additionally, the invention explores the use of CYP2J2 agonists or metabolites in conjunction with transient receptor potential vanilloid 1 (TRPV1) agonists for treating disorders responsive to TRPV1 agonists.
Career Highlights
Sebastian Zinn is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a prestigious research organization in Germany known for its cutting-edge contributions to applied research. His work in neuropathic pain management underscores his commitment to developing effective therapeutic solutions for patients experiencing pain related to cancer treatments.
Collaborations
In his pursuit of innovation, Sebastian Zinn collaborates with esteemed colleagues, including Marco Sisignano and Christian Brenneis. Their collective expertise enhances the potential impact of their research in the field of pain management and supports the advancement of novel therapeutic approaches.
Conclusion
Sebastian Zinn's pioneering work in developing CYP2J2 antagonists represents a significant advancement in the treatment of neuropathic pain, particularly related to chemotherapy. His contributions, alongside the collaboration with skilled professionals, pave the way for improved patient care and highlight the importance of innovations in the medical field. Through his efforts, Zinn exemplifies the critical role of inventors in addressing complex healthcare challenges.